ACE inhibitors Flashcards
What are the indications for ACE inhibitors?
1) HTN
2) Chronic heart failure
3) Prevention of adverse cardiovascular events in IHD, Cerebrovascular disease, Peripheral vascular disease
4) Diabetic Nephropathy: to reduce progression of nephropathy
5) Chronic Kidney Disease (CKD) with proteinuria: to reduce proteinuria
What is the MOA of ACE inhibitors
ACE inhibitors inhibit Angiotensin converting enzyme (ACE), which is responsible for converting Angiotensin 1 to Angiotensin 2. Angiotensin 2 is a vasoconstrictor and stimulates Aldosterone secretion. Blockering Angiotensin 2 in:
HTN > vasodialation > lowers BP
CKD > vasodialation of efferent glomerular arteriole > lower intraglomerular pressure, which slows progression of CKD
Chronic heart failure: Reducing aldosterone concentration promotes sodium and water excretion > reduce venous return (preload) > reduce EF
What are the side effects of ACE inhibitors?
Hypotension (particularly after the first dose)
Hyperkalemia (because a lower Aldosterone level promotes K+ retention)
Worsening renal failure (particularly in Renal artery stenosis, as vasoconstriction of the efferent glomerular arteriole is needed to maintain glomerular filtration)
Dry cough (due to an increased level of bradykinin, which is normally inactivated by ACE)
Angioedema
Anaphylactic reactions
ACE inhibitors are contraindicated in ?
Renal artery stenosis
Acute Kidney Injury (AKI)
women who are breastfeeding
Caution in CKD (give at a lower dose & monitor renal function)
Advise that if they develop diarrhoea or vomiting, to maintain their fluid intake, and stop the ACE inhibitor until their symptoms resolve (Why? To reduce the risk of dehydration, low blood pressure, and kidney damage)
Which drugs interact with ACE inhibitors negatively?
Potassium-elevating drugs (potassium supplements, aldosterone antagonists, potassium-sparing diuretics)
NSAID with an ACE inhibitor increases the risk of nephrotoxicity
How do I monitor patients on ACE inhibitors?
For safety, check electrolytes and renal function before starting treatment. Repeat these 1–2 weeks into treatment and after increasing the dose.